Key indications in the oncology pipeline worldwide 2021
Worldwide, 12 percent of clinical drug trials in the oncology pipeline in 2021 were for advanced solid tumors and four percent of trials were for breast cancer. This statistic shows the share of clinical trials in the oncology pipeline worldwide in 2021, by key indication.